000 01619 a2200481 4500
005 20250514224246.0
264 0 _c20051122
008 200511s 0 0 eng d
022 _a0017-5749
024 7 _a10.1136/gut.2005.066621
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNoble, C L
245 0 0 _aDLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.
_h[electronic resource]
260 _bGut
_cOct 2005
300 _a1416-20 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aColitis, Ulcerative
_xepidemiology
650 0 4 _aCrohn Disease
_xepidemiology
650 0 4 _aEpistasis, Genetic
650 0 4 _aFemale
650 0 4 _aGene Frequency
_xgenetics
650 0 4 _aGenetic Predisposition to Disease
_xepidemiology
650 0 4 _aGenotype
650 0 4 _aHaplotypes
_xgenetics
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
_xepidemiology
650 0 4 _aIntracellular Signaling Peptides and Proteins
_xgenetics
650 0 4 _aMale
650 0 4 _aMembrane Proteins
_xgenetics
650 0 4 _aMiddle Aged
650 0 4 _aNod2 Signaling Adaptor Protein
650 0 4 _aPhenotype
650 0 4 _aScotland
_xepidemiology
650 0 4 _aTumor Suppressor Proteins
_xgenetics
700 1 _aNimmo, E R
700 1 _aDrummond, H
700 1 _aSmith, L
700 1 _aArnott, I D R
700 1 _aSatsangi, J
773 0 _tGut
_gvol. 54
_gno. 10
_gp. 1416-20
856 4 0 _uhttps://doi.org/10.1136/gut.2005.066621
_zAvailable from publisher's website
999 _c15511140
_d15511140